There is no cure for the new Novel Corona virus disease Cod-19, and scientists are working hard to develop vaccines and medicines.
At the same time, drugs currently available in various countries are being tested for treatment, including anti-malarial drugs, Ebola drugs, remedies, flu and HIV drugs.
Read Also:Why is the corona virus more deadly in some countries? The answer came
Now scientists in the United States have been designated to promptly deliver an intravenous drug to homes of Cody 19 patients to see how their effects improve their health.
The anti-inflammatory drug Colchicine will be delivered to homes within 48 hours of being diagnosed with the corona virus by the University of California, San Francisco and the New York University School of Medicine.
The study began Tuesday in California, said Dr. Priscilla Hughes, a professor at the University of California.
He said that in the research, shawls would stay at home, which would reduce the risk for others, and would not increase the need for protective clothing and travel.
Read Also:It would be a serious mistake if Pakistan did not include Aamir in the World Cup squad
According to him, we believe that this strategy can be adopted at the global level, which does not require much resources.
This medicine is now used to treat nasty, genetic disorders like Familial Mediterranean Fever and blood vessels arthritis.
The drug will soon be tested not only in the United States but also in the Montreal Heart Institute in Canada and in Europe.
A total of 6,000 patients will be part of these trials.
These trials will include patients who are at least 40 years of age or older who are already prone to other risk factors such as diabetes, cardiovascular disease, lung disease or older.
Read Also:Measures against the Corona Virus also reduce another disease-related mortality
Those who meet this standard will be invited by phone to participate in the trial, and if they accept, a digital license will be signed.
The medicine will then be delivered to their home by courier in a few hours, after which researchers will review the health of the volunteers by phone or video chat 15 to 30 days later.
US researchers say that this is one of the limited trials of Cod-19 that is being performed on patients who have not yet been admitted to the hospital.
He hopes that the drug will help to reduce the risk to the body’s organs by activating the immune system.
According to scientists, the drug has been used for decades for edema, and research has shown that eating it after a heart attack reduces the risk of cardiovascular disease, while also keeping it safe.
Read Also:Can using a face mask really protect against viruses?
“When the drug is used in the early stages of the disease, we expect it to significantly reduce edema and prevent the immune response from over-activating, which is why cod 19 causes respiratory complications,” he said. Causes
The scientists said the drug was safe and would not require strict monitoring of patients, and hoped that the drug’s properties would prevent hospital admissions and the increase in code 19 severity.